I am not sure either. The headline sounds pretty good. The stock is up 5% which doesn't sound like much, but they have a 7.3b~ market cap so it's a reasonable jump. Neuren knew we had competition in this indication but it will be interesting to compare results but it appears the endpoints may be different so that may be difficult ...
Ionis announces positive detailed results from the HALOS Study of ION582 in people with Angelman syndrome
Angelman trial, page-65
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.52 |
Change
0.310(2.04%) |
Mkt cap ! $1.983B | |||
| Open | High | Low | Value | Volume |
| $15.19 | $15.62 | $15.11 | $8.655M | 558.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 440 | $15.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.54 | 752 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |